Navigation Links
Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351
Date:11/18/2008

Randomized study will enroll newly diagnosed, elderly AML patients

PRINCETON, N.J., Nov. 18 /PRNewswire/ -- Celator Pharmaceuticals today announced that the first patient has been treated in a randomized Phase 2 clinical study of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in patients with newly diagnosed acute myeloid leukemia (AML).

The first patient was enrolled by Eric Feldman, MD at the Weill Medical College of Cornell University and New York Presbyterian Hospital. Dr. Feldman was an investigator involved in the Phase 1 study with CPX-351 in patients with advanced leukemias. "We are pleased to be involved in this Phase 2 study based on the encouraging results seen in the Phase 1 study," said Dr. Feldman. "It's important to develop new treatment options for patients and CPX-351 incorporates two of the most active agents used in the treatment of AML."

CPX-351 is a liposomal formulation of cytarabine and daunorubicin delivered in a 5:1 molar ratio shown in preclinical studies to represent a synergistic ratio for use in combination chemotherapy. CPX-351 represents a new approach to developing drug combinations in which drug ratios are pre-selected based on synergistic anti-tumor activity observed preclinically and where the ratios are maintained in patients through Celator's proprietary CombiPlex(R) technology platform.

The Phase 2 study will be conducted in patients with newly diagnosed AML, greater than or equal to 60 but <76 years of age, who are able to tolerate intensive chemotherapy. This randomized (2:1) study is designed to compare CPX-351 to the conventional method of administering cytarabine and daunorubicin, commonly referred to as "7+3." The reference "7+3" refers to the administration days of the drugs (cytarabine is administered as a 7 day continuous infusion and daunorubicin is administered on days 1, 2 and 3). CPX-351 is administer
'/>"/>

SOURCE Celator Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Celator(R) Pharmaceuticals Announces Positive Phase 2 Results for CPX-1 in Treatment of Colorectal Cancer
2. Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations
3. Celator(R) Pharmaceuticals Reports CPX-351 Shows Anti-Cancer Activity in Leukemia Patients
4. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
5. Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire dAngers for Phase II Clinical Trial in Huntingtons Disease
6. VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease
7. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
8. Poniard Pharmaceuticals Announces Final Top-Line Results from Phase 1 Trial Demonstrating Positive Bioavailability with Oral Picoplatin
9. VIA Pharmaceuticals Announces Conference Call and Webcast to Discuss VIA-2291 Phase 2 Data Presentations at AHA
10. Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium
11. Raptor Pharmaceuticals Provides Update on Targeting Platforms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... More than fifty years ago, Thalidomide was approved by Health ... Tragically, Thalidomide caused serious and permanent physical and emotional damage ... been provided to survivors over the years from sources including ... in 1991 and settlements from drug companies. ... support, we have a clear moral obligation to help meet ...
(Date:5/22/2015)... ORLANDO, Fla. , May 22, 2015 ... Copay Assistance Program. This program provides financial assistance for ... "We are pleased to announce the addition of the ... programs," stated Mark McGreevy , executive director. "With ... mission and vision of a world where no one ...
(Date:5/22/2015)... , May 22, 2015 The North ... 2014 and is estimated to reach $90.7 million by 2019, ... Browse through the TOC of North America Dental Lasers ... the help of various tables and figures. ... customization on this report.   Dental lasers ...
Breaking Medicine Technology:Statement from Minister Ambrose on Thalidomide 2Statement from Minister Ambrose on Thalidomide 3The Assistance Fund Adds Melanoma Assistance Program 2North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 2North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 3
... 2011 Anaphore Inc. today announced that Michael ... joined Anaphore,s senior management team. Dr. ... and development partnership with Mitsubishi Tanabe Pharma Corporation, ... shaping Anaphore,s corporate strategy. Mr. Logan will work ...
... (NASDAQ: CPHD ) today announced it ... the largest privately held distributor of clinical products in the ... Cepheid,s GeneXpert® Systems and tests. The agreement grants LABSCO ... for institutions with less than 150 beds. The agreement does ...
Cached Medicine Technology:Anaphore Appoints Michael F. Haller, Ph.D., Senior Vice President of Strategic Partnerships and H Casey Logan Senior Vice President of Business Development 2Anaphore Appoints Michael F. Haller, Ph.D., Senior Vice President of Strategic Partnerships and H Casey Logan Senior Vice President of Business Development 3Cepheid Appoints LABSCO as US Small Hospital Distributor 2Cepheid Appoints LABSCO as US Small Hospital Distributor 3Cepheid Appoints LABSCO as US Small Hospital Distributor 4
(Date:5/24/2015)... NY (PRWEB) May 24, 2015 The ... Sunday, May 24th in San Diego at Petco Park. ... North America. On May 20th, they had a warmup ... At their preview show in Los Angeles, this beloved band ... they also played fan favorites such as "Jumping Jack Flash," ...
(Date:5/24/2015)... May 24, 2015 For people who ... Chinese Enterokinase Industry, 2009-2019 Market Research Report would be ... an exhaustive study on the present market scenario of ... into the growing Chinese market of this industry. The ... overall status of the manufacturers in this industry. The ...
(Date:5/24/2015)... 24, 2015 Scientists with Cardno ChemRisk, ... air quality compliance issues that may have raised the ... Mesothelioma has just posted an article on the research. ... The group found airborne asbestos levels well above OSHA ... 1984 and 2011. , “Asbestos compliance sampling data associated ...
(Date:5/24/2015)... 24, 2015 The federal court ... ) has scheduled its next monthly Case Management ... litigation. According to court documents filed in the ... Conference will be convened on June 2, 2015, ... Product Liability Litigation - MDL No. 2545) , ...
(Date:5/24/2015)... Indianapolis, Indiana (PRWEB) May 24, 2015 ... network service provider announces Midwest Telecom of America, Inc. ... , According to Cory Childs, IFN Enterprise Sales ... to service providers. “IFN’s fiber transport provides MTA ... Operations Center to their Tier 1 Internet and voice ...
Breaking Medicine News(10 mins):Health News:The Rolling Stones Tickets in San Diego, Orlando, Minneapolis, Dallas, Pittsburgh, Indianapolis, Atlanta, Detroit, Milwaukee, Kansas City, Columbus, Nashville & Raleigh 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 3Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 4Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 3Health News:Indiana Fiber Network, LLC Enables Midwest Telecom of America with Fiber Route Diversity 2
... say that following a Mediterranean diet consisting of plenty of ... level of inflammation in the aged and elderly people. This ... in such individuals. ,The reserachers tracked the level ... an average age of 66 years. The effect of the ...
... Mike Johanns said that the department officials are working on ... of banned cattle // parts to that country. Johanns said ... officials. ,"We have received the questions from Japan ... Johanns told reporters. “I did not see anything in those ...
... adrenaline rush at Disneyland Paris, though now, it appears to ... Ruffled up, Disney land Paris is shrugging away the allegation ... news, as panic over bird flu is all over Europe. ... the French Democratic Workers Confederation and Workers’ Force, spotted a ...
... Tissue Services has been accused of stealing HIV infected ... distributing it to various hospitals without testing// it. ... following transplantation of bone tissue, according to lawyers who ... victim is believed to have contracted HIV following cervical ...
... to cut off nearly 300 jobs after it put to ... huge losses. //Royal Cornwall Hospitals Trust is facing a mammoth ... million which might force it to close wards and operating ... (MFF) has perhaps caused this downslide, because it works on ...
... finally given to the redevelopment of St Bartholomew’s and the ... the most expensive PFI (private finance initiative) project in Britain. ... not all the money would be brought into action immediately. ... the Royal London will not be fitted out until it ...
Cached Medicine News:Health News:HIV Infected Body Parts Stolen: Biomedical Tissue Services To Face Legal Action 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: